Adage Capital Partners Gp, L.L.C. Scholar Rock Holding Corp Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.84 - $16.79 $3.14 Million - $6.72 Million	-400,000 Reduced 76.19%	125,000 $1.04 Million
Q1 2024 May 15, 2024	SELL	$13.2 - $17.76 $10.2 Million - $13.8 Million	-775,000 Reduced 59.62%	525,000 $9.32 Million
Q4 2023 Feb 14, 2024	BUY	$6.52 - $20.32 $8.48 Million - $26.4 Million	1,300,000 New	1,300,000 $24.4 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.